Table 1.
Oligonucleotide Sequence |
|||
Exon(s) | Forward | Reverse | Product Size(bp) |
1a | GAGTCCCCATAAGCCTCT | TTCCTCCTCCCTTTTCTCT | 552 |
2a | CCCCTGCTTTGTAAGTAAGA | TAATCCCTCGGTTTCCTC | 300 |
3a | AAAACTGGAAATGGAAGACA | ATTGCTTGGACCTGGAAG | 453 |
4a | CCAACTAGGTTTGCTTTCAC | GCACCGATAAGAGTTCATTC | 478 |
5a | CTCAGAAATGTGCTTTTTCC | AACAGGCATAAGATGGCTAA | 238 |
6a | TCATGACACCTGCTTTACAA | ACAGTAGGGAAGGAAGATCC | 359 |
7a | GCTAATGAATTCTGCTTTGC | GAAACCAAACGCCATAAAGT | 441 |
8a | GAAGTGATTGCGCTTAACAT | CAACTAGGCATAAACCAACATC | 280 |
9a | TAAAGTGCATCCCATATCCT | TGGCTAGATTAGCAACCATT | 358 |
10a | ATTACCAGTCAGAACCACCA | CCTTCAGGAGGGACTGATA | 400 |
4–10b | GTGAATGAAGATTCCTCTGC | CCTTCAGGAGGGACTGATA | 802 |
Genomic DNA amplification was performed for this exon with the use of PCR primers; mutation detection was done by direct sequencing. Coding exons include exons 4–10.
cDNA studies were performed for these exons by the use of RT-PCR primers.